Goldman Sachs’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-79,450
| Closed | -$976K | – | 5427 |
|
|
2022
Q4 | $976K | Buy |
79,450
+10,627
| +15% | +$131K | ﹤0.01% | 3710 |
|
|
2022
Q3 | $2.26M | Buy |
68,823
+58,082
| +541% | +$1.91M | ﹤0.01% | 3277 |
|
|
2022
Q2 | $202K | Sell |
10,741
-2,821
| -21% | -$53.1K | ﹤0.01% | 4894 |
|
|
2022
Q1 | $238K | Buy |
+13,562
| New | +$238K | ﹤0.01% | 5003 |
|